UNSPSC 85352106: Diagnosis of drug-induced pemphigus

This classification denotes the group of activities that yields a diagnosis of Drug-induced pemphigus. Drug-induced pemphigus is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code L10. 5

UNSPSC 85352106 Diagnosis of drug-induced pemphigus is a Commodity code showing minimal alignment with recent state and local procurement activity. The three most recent opportunities posted under this code span diagnostic imaging systems, special education contracted services, and temporary health professional staffing — none of which directly address drug-induced pemphigus diagnosis or related dermatological services. The mismatch suggests either miscoding in the source data or that state and local procurement offices are applying this code outside its nominal clinical scope.

San Mateo Medical Center (SMMC) in California posted an RFP on October 7, 2026 (due October 21, 2026) for Diagnostic Imaging PACS implementation integrating with EPIC, supporting radiology, cardiology, and dental imaging with enterprise-grade uptime and migration requirements — unrelated to pemphigus diagnosis. Birdville Independent School District in northeast Tarrant County, Texas posted a competitive sealed proposal on September 18, 2026 (due October 21, 2026) for special education contracted services across 23 line items including audiologists, diagnosticians, and therapists — also unrelated to the code's stated scope. Santa Clara Health System in California solicited temporary health professional staffing qualifications posted July 7, 2026 (due October 7, 2026) across ancillary clinical categories including diagnostic imaging, cardiology, and therapy services, again with no connection to dermatological or pemphigus-related diagnosis. The code shows no recent relevant procurement activity among state and local buyers.